High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV) — HELP

Pathologic Myopia Clinical Trial

Official title:
High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV)

Status Completed

Clinical Trial Summary

This research project intends to observe patients with high myopia who show pathological retinal changes, in order to evaluate more data on the risk factors for developing mCNV within this research project population in Germany.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03070717
Study type	Observational
Source	Novartis
Contact
Status	Completed
Phase
Start date	June 12, 2014
Completion date	May 23, 2019

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT03666052` - Shanghai Child and Adolescent Large-scale Eye Study -High Myopia Registration
Recruiting	`NCT06322433` - Follow up of High Myopic Eyes
Completed	`NCT03963596` - Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia	N/A
Completed	`NCT04723160` - Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph
Recruiting	`NCT04976244` - Brolucizumab for CNV Associated With Pathologic Myopia	N/A